Clinical Trials
2 trialsNCT05603039 2022-11-02
A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
NCT04163237 2019-11-14
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
Guangxi Medical University
Phase 3 Unknown